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Summary. — Two applications for neutron capture therapy of epithermal neutron
beams calculated from the 7Li(p,n) reaction are discussed. In particular, i) for a
proton beam of 1920 keV of a 30 mA, a neutron beam of adequate features for BNCT
is found at an angle of 80◦ from the forward direction; and ii) for a proton beam
of 1910 keV, a neutron beam is obtained at the forward direction suitable for per-
forming radiobiology experiments for the determination of the biological weighting
factors of the fast dose component in neutron capture therapy.
1. – Description
Boron Neutron Capture Therapy (BNCT) [1] is an experimental form of radiotherapy
based on the selective uptake of a boron compound by tumor cells and the subsequent
irradiation of the tumor with a low energy neutron beam producing a thermal neutron
field in the tumor. Thermal neutrons are captured by the boron atoms by means of a
(n, α) reaction in which high-energy heavy charged particles are delivered locally to the
tumor. These particles have a significantly higher linear energy transfer to the medium
(tumor) than photons or electrons, and therefore are more biologically effective than
conventional radiotherapy. Up to now, all clinical trials of BNCT have been performed
from research reactor neutron sources. These neutron sources are scarce and are not
practical for construction in hospitals. For this reason, accelerator-based neutron sources
(ABNS) are in development in several countries, and in Kyoto (Japan), an ABNS is ready
for medical applications [2]. The ABNS in Japan is based on collisions of 30MeV protons
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from a cyclotron with a Be target. Another option, which requires a lower energy proton
beam, is based on the (p, n) reaction on 7Li near the threshold. This produces a less
energetic neutron beam thus requiring minor moderation for use in patient irradiation [3].
For BNCT, the spectrum of the neutron beam is critical. The neutrons should have
enough energy to penetrate deeply in the body, but not so high as to produce a large
background radiation dose, while also being able to thermalize within the body. These
features require an initial epithermal spectrum for the neutrons, but the exact require-
ments should be determined with Monte Carlo simulations.
All the neutrons beams used in BNCT up to now have been obtained with some
moderation from the source, in order to obtain a spectrum in which more than 90% of
the neutrons are in the epithermal range. This is defined as the interval [0.5 eV, 10 keV].
However the upper bound is just a reference value and slightly greater energies can
be also suitable for BNCT. For example, it has been shown by MC simulation how a
monoenergetic beam of 13.5 keV can be very appropriate for BNCT [4].
The optimization of the neutron spectrum for BNCT is a question of compromise.
Higher energies than 20 keV produce an undesirable maximum of the absorbed dose in
the surface of the phantom (which raises steeply when increasing the neutron energy),
and energies below 1 keV would reduce strongly the penetrability of the beam in order
to reach deeper located tumors. The moderation of a neutron beam necessarily produce
a strong broadening of the spectrum. Our aim in this work is trying to obtain a neutron
spectrum as close as possible to epithermal energies around 10 keV. For this purpose we
have analyzed the neutron spectrum obtained from the 7Li(p, n) reaction near the neutron
production threshold (between 1.88MeV and 2MeV) and at certain angles from the beam
direction. Although the neutron yield reduces strongly when decreasing the proton energy
from the 2.5MeV resonance, and also at increasing angles from the forward direction,
the possibility of not needing moderation could be enough for certain BNCT applications
when a very high current accelerator (20–30mA) as those recently available is used.
In this work we will perform calculations of an entire procedure for an accelerator-
based BNCT application starting from the 7Li(p, n) reaction. We will explore, for proton
energies near the threshold and different exit angles, the possibility of obtaining an
epithermal neutron spectrum which produces a depth-dose distribution in a body model
appropriate for a BNCT treatment. A second problem would be obtaining a suitable
beam for BNCT basic research (cell culture irradiation by epithermal neutrons), even
with a low current accelerator. This is interesting for the experimental determination of
the relative biological effectiveness (RBE) factors of epithermal neutrons.
2. – Methods
The form of the neutron spectrum as a function of the neutron energy and the exit
angle, important ingredient in our simulations, is the thick target differential neutron
yield that can be calculated as
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dEp
dEn
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dEp
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where Ω(Ω′) is the solid angle in the laboratory (center of mass) system of reference,
En(Ep) is the neutron (proton) energy in the laboratory system, f7Li = 0.925 is the
fraction of 7Li in natural lithium metal (target composition), dσpndΩ′ is the differential
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cross section of the reaction in the center-of-mass system, n is the density of atoms in
the target and the whole denominator is the mass stopping power of protons in the
medium.
In the same way as Lee and Zhou [5], we have adjusted a cubic spline to the experi-
mental data of the differential cross section from Lisken and Paulsen [6] and we have used
analytical expressions for the mass stopping power [7]. Further details can be consulted
in [5].
2.1. A. Near threshold beam for BNCT . – With the neutron spectra obtained from
these calculations, we have performed MC simulations using the MCNPX code, version
2.5.0 [8]. For this application we have considered the geometry illustrated in fig. 1.
The neutron field obtained from a proton beam of 1920 keV on a thick lithium target
is transported in a cylindrical phantom of 8 cm radius, 10 cm height. The material in
this cylinder is a representative soft tissue called 4-component soft tissue as defined
by the International Commission on Radiation Units (ICRU) with the following mass
composition: 10.12% H, 76.18% O, 11.10% C and 2.60% N. The axis of the cylinder is
placed at an angle with respect to the proton beam direction of 80◦ and at a distance
of 5 cm. This situation has been selected from different choices of angles because it has
shown to be adequate for the depth-dose distribution inside the phantom.
2.2. B. Epithermal beam for in-vitro radiobiology experiments. – The dose in a BNCT
treatment is usually decomposed in different contributions: boron, thermal (mainly due
to the protons emitted in the Nitrogen capture reaction), fast (mainly due to the recoiling
protons from elastic collisions of the neutrons at epithermal energies) and photon dose.
Our goal is designing a method to evaluate separately the RBE factors of the fast and
thermal dose for the same type of cells. The RBE factors are defined as the ratio between
the dose required for a photon irradiation and the actual field, producing both the same
biological effect.
For obtaining these factors we can measure the biological effect after the irradiation
with two different neutron beams, one producing much more thermal than fast dose
and another just the opposite. The former case happens under thermal beams as those
obtained from reactors after neutron moderation. In this work we will design an exper-
imental condition producing much more epithermal dose than thermal, which would be
the second case required.
The situation studied, representing the irradiation of adherent cells, is the following:
80o
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Fig. 1. – Schematics of the neutron irradiation of the cylindrical phantom of 8 cm radius, 10 cm
height. The distance between the phantom and the center of the Li target is 5 cm.
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Fig. 2. – Schematics of the neutron irradiation of culture cells. The dimensions are as follows:
beam diameter 6mm, Li thick target of 2 cm diameter, distance target-cells 1 cm, diameter of
culture 2 cm, 1 cm water beyond the cells.
the neutron field produced by a proton beam of 1910 keV (±1 keV) on a thick lithium
target is directed to a very thin layer of cells (represented by the same 4-component
ICRU tissue). This cells are in a box of basis 6× 6 cm, and 2 cm height, filled by water
(representing the culture medium). The situation is illustrated in fig. 2.
3. – Results
3.1. Application A. – The absorbed dose depth profile at the phantom axis is illus-
trated in fig. 3. In both panels, the solid line corresponds to the tumor dose assuming a
concentration of boron of 40 ppm, while the dotted line, representing the normal tissue
dose, is found assuming a concentration of 10 ppm. In the left panel, it is noticed how
the tumor absorbed dose is greater than the maximum of the normal tissue dose (hori-
zontal dotted line) up to a depth of about 8 cm (advantage depth), and how in the range
between 2 and 5 cm depth, the tumor dose exceeds twice the maximum normal tissue
dose (horizontal solid line). In the right panel the biological dose is estimated using the
weighting factors of use in BNCT: 3.2 for the fast and thermal doses, 1.0 for the gamma
dose, and for the boron dose values of 3.8 (tumor) and 1.8 (normal tissue). We can
see in the plot the important enhancement of the weighted dose delivered to the tumor
compared to the normal tissue one.
The results are illustrated for a reference proton beam intensity of 1mA. The low
dose rates obtained for this intensity are expected because the low neutron yield near
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Fig. 3. – Absorbed (left) and weighted (right) dose rate depth profile in the phantom axis at
tumor cells (solid curve) and normal cells (dotted curve). The horizontal lines represent the
maximum value of the normal tissue dose rate (dotted) and twice this value (solid).
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Table I. – Dose rate components at the cell culture, for a proton beam of 1910 keV and a thick
Li target for different beam currents.
Component Gy/min (1mA) Gy/h (10μA)
Df 1.370 0.822
Dt 8.34× 10−4 5.00× 10−4
the threshold and at this angle. However, with a high current accelerator (30mA) the
weighted dose rate at the tumor could reach values between 10 and 20Gy/h (3.8Gy/h
maximum for normal tissue).
The reason of the high differences between the tumor and normal tissue dose can be
addressed to the low values of the fast dose component, which is due to the low-energy
spectrum of the neutrons. This is a difference with respect to previous calculations of
the dose produced by this reaction in the forward direction, where a high peak at the
surface of the phantom usually appears due to the higher energy delivered by the most
energetic neutrons in their first elastic collision in the medium.
3.2. Application B . – The results of the MC calculation of the absorbed dose rate
produced at the cells represented by the disk of 2 cm in fig. 2 with the MCNPX code
above mentioned are shown in table I. The fast dose component is much greater than
the thermal one, which is the situation pursued. The values of the fast dose rate is
high enough as to measure survival effects in cells (usually starting from 0.1Gy) in a
reasonable time, even if a low current accelerator (in the μA range) is available. This
measurements then would complement those performed with a thermal beam in which
the situation is the opposite (in terms of relative dose contributions).
4. – Conclusions
Epithermal neutron beams obtained from the 7Li(p, n) reaction near the threshold
can be useful for neutron capture therapy, both for basic research and for therapy. In
the first case, with an energy of the proton beam of 1910 keV, the neutron beam at the
forward direction is adequate for radiobiology experiments even if the accelerator has
a low current. For the latter, in this work it has been analyzed a very simplistic case,
but the results for a proton beam energy of 1920 keV and a phantom located at 80◦ are
promising. Therefore it seems interesting to research further in this direction with more
realistic calculations and experimentation.
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